Clinical Trial Update: ABY-029 Head & Neck Trial [Phase 1]

View source ↗

Summary

Phase 1 trial update for ABY-029 in head and neck squamous cell carcinoma. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• ABY-029

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: NOT_YET_RECRUITING